Multiple sclerosis, which is the most common cause of chronic neurological disability in young adults, is an inflammatory, demyelinating, and neurodegenerative disease of the CNS, which leads to the formation of multiple foci of demyelinated lesions in the white matter. The diagnosis is based currently on magnetic resonance image and evidence of dissemination in time and space. However, this could be facilitated if biomarkers were available to rule out other disorders with similar symptoms as well as to avoid cerebrospinal fluid analysis, which requires an invasive collection. Additionally, the molecular mechanisms of the disease are not completely elucidated, especially those related to the neurodegenerative aspects of the disease. The identification of biomarker candidates and molecular mechanisms of multiple sclerosis may be approached by proteomics. In the last 10 years, proteomic techniques have been applied in different biological samples (CNS tissue, cerebrospinal fluid, and blood) from multiple sclerosis patients and in its experimental model. In this review, we summarize these data, presenting their value to the current knowledge of the disease mechanisms, as well as their importance in identifying biomarkers or treatment targets. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.1404/05/15467480Hauser, S.L., Oksenberg, J.R., The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration (2006) Neuron, 52, pp. 61-76Hafler, D.A., Slavik, J.M., Anderson, D.E., O'Connor, K.C., Multiple sclerosis (2005) Immunol. Rev., 204, pp. 208-231Lassmann, H., Multiple sclerosis: is there neurodegeneration independent from inflammation (2007) J. Neurol. Sci., 259, pp. 3-6Kieseier, B.C., Wiendl, H., Leussink, V.I., Stuve, O., Immunomodulatory treatment strategies in multiple sclerosis (2008) J. Neurol., 255, pp. 15-21Nylander, A., Hafler, D.A., Multiple sclerosis (2012) J. Clin. Invest., 122, pp. 1180-1188Lassmann, H., van Horssen, J., Mahad, D., Progressive multiple sclerosis: pathology and pathogenesis (2012) Nat. Rev. Neurol., 8, pp. 647-656Sadovnick, A.D., Dyment, D.A., Ebers, G.C., Risch, N.J., Evidence for genetic basis of multiple sclerosis (1996) Lancet, 347, pp. 1728-1730Dyment, D.A., Ebers, G.C., Sadovnick, A.D., Genetics of multiple sclerosis (2004) Lancet Neurol., 3, pp. 104-110Munger, K.L., Zhang, S.M., O'Reilly, E., Hernan, M.A., Vitamin D intake and incidence of multiple sclerosis (2004) Neurology, 62, pp. 60-65Ramagopalan, S.V., Anderson, C., Sadovnick, A.D., Ebers, G.C., Genomewide study of multiple sclerosis (2007) N. Engl. J. Med., 357, pp. 2199-2200Apperson, M.L., Tian, Y., Stamova, B., Ander, B.P., Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study (2013) J. Neuroimmunol., 257, pp. 90-96Haines, J.L., Ter-Minassian, M., Bazyk, A., Gusella, J.F., A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group (1996) Nat. Genet., 13, pp. 469-471Genome-wide association study of severity in multiple sclerosis (2011) Genes Immun., 12, pp. 615-625. , International Multiple Sclerosis Genetics Consortium(2013) Am. J. Hum. Genet., 92, pp. 854-865. , International Multiple Sclerosis Genetics Consortium, Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 ControlsPatsopoulos, N.A., Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci (2011) Ann. Neurol., 70, pp. 897-912. , Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist, ANZgene ConsortiumBaranzini, S.E., Nickles, D., Genetics of multiple sclerosis: swimming in an ocean of data (2012) Curr. Opin. Neurol., 25, pp. 239-245Noseworthy, J.H., Bass, B.H., Vandervoort, M.K., Ebers, G.C., The prevalence of primary sjogren's syndrome in a multiple sclerosis population (1989) Ann. Neurol., 25, pp. 95-98Nielsen, N.M., Westergaard, T., Frisch, M., Rostgaard, K., Type 1 diabetes and multiple sclerosis: a Danish population-based cohort study (2006) Arch. Neurol., 63, pp. 1001-1004Compston, A., Coles, A., Multiple sclerosis (2002) Lancet, 359, pp. 1221-1231Roosendaal, S., Geurts, J., Vrenken, H., Hulst, H., Regional DTI differences in multiple sclerosis patients (2009) NeuroImage, 44, pp. 1397-1403De Stefano, N., Matthews, P.M., Filippi, M., Agosta, F., Evidence of early cortical atrophy in MS: relevance to white matter changes and disability (2003) Neurology, 60, pp. 1157-1162Geurts, J.J.G., Bö, L., Pouwels, P.J.W., Castelijns, J.A., Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology (2005) Am. J. Neuroradiol., 26, pp. 572-577Pirko, I., Lucchinetti, C.F., Sriram, S., Bakshi, R., Gray matter involvement in multiple sclerosis (2007) Neurology, 68, pp. 634-642Fisniku, L.K., Chard, D.T., Jackson, J.S., Gray matter atrophy is related to long-term disability in multiple sclerosis (2008) Ann. Neurol., 64, pp. 247-254Dalton, C.M., Chard, D.T., Davies, G.R., Miszkiel, K.A., Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes (2004) Brain, 127, pp. 1101-1107Fisher, E., Lee, J.C., Nakamura, K., Rudick, R.A., Gray matter atrophy in multiple sclerosis: a longitudinal study (2008) Ann. Neurol., 64, pp. 255-265Brownell, B., Hughes, J.T., The distribution of plaques in the cerebrum in multiple sclerosis (1962) J. Neurol. Neurosurg. Pschiatr., 25, pp. 315-320Rivers, T.M., Sprunt, D.H., Berry, G.P., Observations on attempts to produce acute disseminated encephalomyelitis in monkeys (1933) J. Exp. Med., 58, pp. 39-53Baxter, A.G., The origin and application of experimental autoimmune encephalomyelitis (2007) Nat. Rev. Immunol., 7, pp. 904-912Farias, A.S., Talaisys, R.L., Blanco, Y.C., Lopes, S.C.P., Regulatory T cell induction during Plasmodium chabaudi infection modifies the clinical course of experimental autoimmune encephalomyelitis (2011) PLoS ONE, 6, pp. e17849Farias, A.S., Spagnol, G.S., Bordeaux-Rego, P., Oliveira, C.O.F., Vitamin D3 inducesIDO(+) tolerogenic DCs and enhances Treg, reducing the severity of EAE (2013) CNS Neurosci. Ther., 19, pp. 269-277Flugel, A., Willem, M., Berkowicz, T., Wekerle, H., Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses (1999) Nat. Med., 5, pp. 843-847Kuchroo, V.K., Martin, C.A., Greer, J.M., Ju, S.T., Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis (1993) J. Immunol., 151, pp. 4371-4382Steinman, L., A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage (2007) Nat. Med., 13, pp. 139-145O'Connor, R.A., Prendergast, C.T., Sabatos, C.A., Lau, C.W.Z., Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis (2008) J. Immunol., 181, pp. 3750-3754Bartholomäus, I., Kawakami, N., Odoardi, F., Schläger, C., Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions (2009) Nature, 462, pp. 94-98Pradella, F., Moraes, A.S., Santos, M.P.A., Depaula, R.F.O., Granulocyte colony-stimulating factor treatment enhances Foxp3(+) T lymphocytes and modifies the proinflammatory response in experimental autoimmune neuritis (2013) CNS Neurosci. Ther., 19, pp. 529-532Emamaullee, J.A., Davis, J., Merani, S., Toso, C., Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice (2009) Diabetes, 58, pp. 1302-1311Korn, T., Bettelli, E., Oukka, M., Kuchroo, V.K., IL-17 and Th17 Cells (2009) Annu. Rev. Immunol., 27, pp. 485-517Flugel, A., Berkowicz, T., Ritter, T., Labeur, M., Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis (2001) Immunity, 14, pp. 547-560Kang, Z., Liu, L., Spangler, R., Spear, C., IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination (2012) J. Neurosci., 32, pp. 8284-8292Farias, A.S., de La Hoz, C., Castro, F.R., Oliveira, E.C., Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination (2007) Neuroimmunomodulat., 14, pp. 32-38Goverman, J., Autoimmune T cell responses in the central nervous system (2009) Nat. Rev. Immunol., 9, pp. 393-407Plant, S.R., Iocca, H.A., Wang, Y., Thrash, J.C., Lymphotoxin β receptor (LtβR): dual roles in demyelination and remyelination and successful therapeutic intervention using LtβR-Ig protein (2007) J. Neurosci., 27, pp. 7429-7437Fabis, M.J., Scott, G.S., Kean, R.B., Koprowski, H., Hooper, D.C., Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 5656-5661Bettini, M., Vignali, D.A., Regulatory T cells and inhibitory cytokines in autoimmunity (2009) Curr. Opin. Immunol., 21, pp. 612-618Wing, K., Sakaguchi, S., Regulatory T cells exert checks and balances on self tolerance and autoimmunity (2010) Nat. Immunol., 11, pp. 7-13Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M., Regulatory T cells and immune tolerance (2008) Cell, 133, pp. 775-787Hori, S., Nomura, T., Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3 (2003) Science, 299, pp. 1057-1061Kitani, A., Chua, K., Nakamura, K., Strober, W., Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells (2000) J. Immunol., 165, pp. 691-702Carrier, Y., Yuan, J., Kuchroo, V.K., Weiner, H.L., Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity (2007) J. Immunol., 178, pp. 172-178Jaros, J.A., Guest, P.C., Bahn, S., Martins-de-Souza, D., Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis (2013) Methods Mol. Biol., 1002, pp. 1-11Koutroukides, T.A., Guest, P.C., Leweke, F.M., Bailey, D.M.D., Characterization of the human serum depletome by label-free shotgun proteomics (2011) J. Sep. Science, 34, pp. 1621-1626Dagley, L.F., Emili, A., Purcell, A.W., Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis (2013) Prot. Clin. Appl., 7, pp. 91-108Nilsson, C., Lindvall-Axelsson, M., Owman, C., Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system (1992) Brain Res. Brain Res. Rev., 17, pp. 109-138Polman, C.H., Reingold, S.C., Banwell, B., Wu, Q., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria (2011) Ann. Neurol., 69, pp. 292-302Hsueh, C.J., Kao, H.W., Chen, S.Y., Lo, C.P., Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis (2013) J. Neurol. Sci., 329, pp. 51-54Link, H., Huang, Y.M., Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness (2006) J. Neuroimmunol., 180, pp. 17-28Sartori, S., Priante, E., Pettenazzo, A., Marson, P., Intrathecal synthesis of oligoclonal bands in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome: new evidence supporting immunological pathogenesis (2013) J. Child Neurol., , DOI 10.1177/0883073812469050Ticozzi, N., Tiloca, C., Mencacci, N.E., Morelli, C., Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations (2013) J. Neurol., 260, pp. 85-92Haghighi, S., Andersen, O., Nilsson, S., Rydberg, L., Wahlström, J., A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy (2006) Mult. Scler., 12, pp. 723-730von Glehn, F., Farias, A.S., de Oliveira, A.C.P., Damasceno, A., Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients (2012) Mult. Scler., 18, pp. 1038-1041Archelos, J.J., Hartung, H.P., Pathogenetic role of autoantibodies in neurological diseases (2000) Trends Neurosci., 23, pp. 317-327Haase, C.G., Schmidt, S., Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100β and myelin basic protein in patients with Devic's neuromyelitis optica (2001) Neurosci. lett., 307, pp. 131-133Oliveira, E.C., Fujisawa, M.A.R.M., Hallal Longo, D.E.M., Farias, A.S., Neuropathy of gastrointestinal chagas' disease: immune response to myelin antigens (2009) Neuroimmunomodulation, 16, pp. 54-62Martins-de-Souza, D., Guest, P.C., Vanattou-Saifoudine, N., Harris, L.W., Bahn, S., Proteomic technologies for biomarker studies in psychiatry: advances and needs (2011) Int. Rev. Neurobiol., 101, pp. 65-94Brewis, I.A., Brennan, P., Proteomics technologies for the global identification of proteins (2010) Adv. Protein. Chem. Struct. Biol., 80, pp. 1-44Anderson, N.L., Anderson, N.G., The Human plasma proteome: history, character, and diagnostic prospects (2002) Mol. Cell. Proteomics, 1, pp. 845-867Colten, H.R., Rosen, F.S., Complement deficiencies (1992) Annu. Rev. Immunol., 10, pp. 809-834Ricciotti, E., FitzGerald, G.A., Prostaglandins and inflammation (2011) Arterioscler. Thromb. Vasc. Biol., 31, pp. 986-1000York, I.A., Rock, K.L., Antigen processing and presentation by the class I major histocompatibility complex 1 (1996) Annu. Rev. Immunol., 14, pp. 369-396Tumani, H., Hartung, H.P., Hemmer, B., Teunissen, C., Cerebrospinal fluid biomarkers in multiple sclerosis (2009) Neurobiol. Dis., 35, pp. 117-127Reiber, H., Ungefehr, S., Jacobi, C., The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis (1998) Mult. Scler., 4, pp. 111-117Ayoglu, B., Haggmark, A., Khademi, M., Olsson, T., Autoantibody profiling in multiple sclerosis using arrays of human protein fragments (2013) Mol. Cell. Proteomics, 12, pp. 2657-2672Mahley, R.W., Weisgraber, K.H., Huang, Y., Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease (2006) Proc. Natl. Acad. Sci. U.S.A., 103, pp. 5644-5651Mahley, R.W., Huang, Y., Apolipoprotein e sets the stage: response to injury triggers neuropathology (2012) Neuron, 76, pp. 871-885Vitek, M.P., Brown, C.M., Colton, C.A., APOE genotype-specific differences in the innate immune response (2009) Neurobiol. Aging, 30, pp. 1350-1360Laskowitz, D.T., Lee, D.M., Schmechel, D., Staats, H.F., Altered immune responses in apolipoprotein E-deficient mice (2000) J. Lipid Res., 41, pp. 613-620Perretti, M., D'Acquisto, F., Annexin A1 and glucocorticoids as effectors of the resolution of inflammation (2009) Nat. Rev. Immunol., 9, pp. 62-70Chiara, A.D., Pederzoli-Ribeil, M., Burgel, P.R., Danel, C., Witko-Sarsat, V., Targeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation (2012) Front. Immunol., 3, p. 311Farias, A.S., Martins-de-Souza, D., Guimarães, L., Pradella, F., Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis (2012) Proteomics, 12, pp. 2656-2662Norgren, N., Sundstrom, P., Svenningsson, A., Rosengren, L., Neurofilament and glial fibrillary acidic protein in multiple sclerosis (2004) Neurology, 63, pp. 1586-1590Sofroniew, M.V., Reactive astrocytes in neural repair and protection (2005) Neuroscientist, 11, pp. 400-407Castegna, A., Thongboonkerd, V., Klein, J.B., Proteomic identification of nitrated proteins in Alzheimer's disease brain (2003) J. Neurochem., 27, pp. 630-633Vosler, P.S., Brennan, C.S., Chen, J., Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration (2008) Mol. Neurobiol., 38, pp. 78-100Ray, S., Banik, N., Calpain and Its Involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration (2003) Curr. Drug Targets CNS Neurol. Disord., 2, pp. 173-189Rosenberg, G.A., Matrix metalloproteinases and their multiple roles in neurodegenerative diseases (2009) Lancet Neurol., 8, pp. 205-216Srivastava, R., Aslam, M., Kalluri, S.R., Schirmer, L., Potassium channel KIR4.1 as an immune target in multiple sclerosis (2012) N. Engl. J. Med., 367, pp. 115-123Oliveira, B.M., Schmitt, A., Falkai, P., Daniel Martins-de-Souza. Is clinical proteomics heading towards to "Bench to Bedside?" (2013) Transl. Proteomics, 1, pp. 53-66Vanheel, A., Daniels, R., Plaisance, S., Baeten, K., Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis (2012) PLoS One, 7, pp. e35544Comabella, M., Fernández, M., Martin, R., Rivera-Vallvé, S., Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis (2010) Brain, 133, pp. 1082-1093Ottervald, J., Franzén, B., Nilsson, K., Andersson, L.I., Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers (2010) J. Proteomics, 73, pp. 1117-1132Stoop, M.P., Dekker, L.J., Titulaer, M.K., Burgers, P.C., Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry (2008) Proteomics, 8, pp. 1576-1585Stoop, M.P., Singh, V., Dekker, L.J., Titulaer, M.K., Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis (2010) PLoS One, 5, pp. e12442Liu, S., Bai, S., Qin, Z., Yang, Y., Cui, Y., Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis (2009) J. Cell Mol. Med., 13, pp. 1586-1603Hammack, B.N., Fung, K.Y., Hunsucker, S.W., Duncan, M.W., Proteomic analysis of multiple sclerosis cerebrospinal fluid (2004) Mult. Scler., 10, pp. 245-260Linker, R.A., Brechlin, P., Jesse, S., Steinacker, P., Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage (2009) PLoS One, 4, pp. e7624Ly, L., Barnett, M.H., Zheng, Y.Z., Gulati, T., Comprehensive tissue processing strategy for quantitative proteomics of formalin-fixed multiple sclerosis lesions (2011) J. Proteome Res., 10, pp. 4855-4868Rithidech, K.N., Honikel, L., Milazzo, M., Madigan, D., Protein expression profiles in pediatric multiple sclerosis: potential biomarkers (2009) Mult. Scler., 15, pp. 455-464Noben, J.P., Dumont, D., Kwasnikowska, N., Verhaert, P., Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry (2006) J. Proteome Res., 5, pp. 1647-1657Rosenling, T., Stoop, M.P., Attali, A., Aken, H.V., Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis (2012) J. Proteome Res., 11, pp. 2048-2060Liu, T., Donahue, K.C., Hu, J., Kurnellas, M.P., Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord (2007) J. Proteome Res., 6, pp. 2565-2575De Masi, R., Vergara, D., Pasca, S., Acierno, R., PBMCs protein expression profile in relapsing IFN-treated multiple sclerosis: a pilot study on relation to clinical findings and brain atrophy (2009) J. Neuroimmunol., 210, pp. 80-86Kroksveen, A.C., Opsahl, J.A., Aye, T.T., Ulvik, R.J., Berven, F.S., Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics (2011) J. Proteomics, 74, pp. 371-388Dumont, D., Noben, J.P., Raus, J., Stinissen, P., Robben, J., Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients (2004) Proteomics, 4, pp. 2117-2124Jastorff, A.M., Haegler, K., Maccarrone, G., Holsboer, F., Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis (2009) Prot. Clin. Appl., 3, pp. 1273-1287Broadwater, L., Pandit, A., Clements, R., Azzam, S., Analysis of the mitochondrial proteome in multiple sclerosis cortex (2011) Biochim. Biophys. Acta, 1812, pp. 630-641Almeras, L., Lefranc, D., Drobecq, H., de Seze, J., New antigenic candidates in multiple sclerosis: identification by serological proteome analysis (2004) Proteomics, 4, pp. 2184-2194Jain, M.R., Bian, S., Liu, T., Hu, J., Altered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cord (2009) Proteome Sci., 7, pp. 1-10Fazeli, A.S., Nasrabadi, D., Sanati, M.H., Pouya, A., Proteome analysis of brain in murine experimental autoimmune encephalomyelitis (2010) Proteomics, 10, pp. 2822-2832Lehmensiek, V., Süssmuth, S.D., Tauscher, G., Brettschneider, J., Cerebrospinal fluid proteome profile in multiple sclerosis (2007) Mult. Scler., 13, pp. 840-849Fainardi, E., Castellazzi, M., Tamborino, C., Trentini, A., Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis (2009) Mult. Scler., 15, pp. 547-554Liu, J., Yin, L., Dong, H., Xu, E., Decreased serum levels of nucleolin protein fragment, as analyzed by bead-based proteomic technology, in multiple sclerosis patients compared to controls (2012) J. Neuroimmunol., 250, pp. 71-76